Opioid dose and drug-related mortality in patients with nonmalignant pain

Archives of Internal Medicine

Volumn 171, Issue 7, 2011, Pages 686-691

  Gomes, Tara ^a,e   Mamdani, Muhammad M ^a,b,c,d,f   Dhalla, Irfan A ^b,d   Michael Paterson, J ^a,f   Juurlink, David N ^a,g  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f ST JOSEPH S HEALTH CENTRE   (Canada)

^g Sunnybrook Health Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE PHOSPHATE; FENTANYL; HYDROMORPHONE; MORPHINE SULFATE; OXYCODONE; PETHIDINE;

ADULT; ARTICLE; ASSOCIATION; BIOEQUIVALENCE; CANADA; CASE CONTROL STUDY; CHRONIC PAIN; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONCANCER PAIN; PAIN; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; CASE-CONTROL STUDIES; DRUG TOXICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; YOUNG ADULT;

EID: 79955122204     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.117     Document Type: Article

References (18)

1. Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani M. Trends in opioid use and dosing in the socioeconomically disadvantaged. Open Med. 2011;5(1):E13-E22.
2. Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009;181(12):891-896.
3. Garcia del Pozo J, Carvajal A, Viloria JM, Velasco A, Garcia del Pozo V. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol. 2008;64(4):411-415.
4. Leong M, Murnion B, Haber PS. Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J. 2009;39(10):676-681.
5. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116-127.
6. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31(6):506-511.
7. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18(12):1166-1175.
8. Franklin GM, Mai J, Wickizer T, Turner JA, Fulton-Kehoe D, Grant L. Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002. Am J Ind Med. 2005;48(2):91-99.
9. . National Opioid Use Guideline Group (NOUGG). Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. http://nationalpaincentre.mcmaster.ca/opioid/. Accessed April 30, 2010.
10. Chou R, Fanciullo GJ, Fine PG, et al; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
11. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief. 2009;(22):1-8.
12. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85-92.
13. Larson EB. Group Health Cooperative: one coverage-and-delivery model for accountable care. N Engl J Med. 2009;361(17):1620-1622.
14. Park-Wyllie LY, Mamdani MM, Li P, Gill SS, Laupacis A, Juurlink DN. Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study. PLoS Med. 2009;6(9):e1000157.
15. Lubin JH, Gail MH. Biased selection of controls for case-control analyses of cohort studies. Biometrics. 1984;40(1):63-75.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
18. Mamdani M, Sykora K, Li P, et al. Reader's guide to critical appraisal of cohort studies, 2: assessing potential for confounding. BMJ. 2005;330(7497):960-962.